Consequences of the natural propensity of Leishmania and HIV-1 to target dendritic cells

Trends in Parasitology

Volumn 23, Issue 7, 2007, Pages 317-324

  Garg, Ravendra ^a   Trudel, Nathalie ^a   Tremblay, Michel J ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C TYPE LECTIN RECEPTOR; CD209 ANTIGEN; CELL ADHESION MOLECULE; FC RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; LECTIN RECEPTOR; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; BINDING SITE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL MATURATION; CELL MIGRATION; CELL SURFACE; CELL TYPE; CELLULAR IMMUNITY; CRYPTOSPORIDIUM PARVUM; DENDRITIC CELL; EOSINOPHIL; FIBROBLAST; GLIA CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LEISHMANIA; LEISHMANIA DONOVANI; LEISHMANIA INFANTUM; LEISHMANIASIS; MACROPHAGE; NEUTROPHIL; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; REVIEW; TOXOPLASMA GONDII;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 34250764110     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2007.05.006     Document Type: Review

References (75)

1. Alvar J., et al. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin. Microbiol. Rev. 10 (1997) 298-319
2. Olivier M., et al. The pathogenesis of Leishmania/HIV co-infection: cellular and immunological mechanisms. Ann. Trop. Med. Parasitol. 97 Suppl. 1 (2003) 79-98
3. Kubar J., et al. Visceral leishmaniasis in HIV-positive patients: primary infection, reactivation and latent infection. Impact of the CD4+ T-lymphocyte counts. AIDS 12 (1998) 2147-2153
4. Murray H.W., et al. Advances in leishmaniasis. Lancet 366 (2005) 1561-1577
5. Stebbing J., et al. Where does HIV live?. N. Engl. J. Med. 350 (2004) 1872-1880
6. Wolday D., et al. Live and killed human immunodeficiency virus type-1 increases the intracellular growth of Leishmania donovani in monocyte-derived cells. Scand. J. Infect. Dis. 30 (1998) 29-34
7. Zhao C., et al. Leishmania infantum enhances human immunodeficiency virus type-1 replication in primary human macrophages through a complex cytokine network. Clin. Immunol. 113 (2004) 81-88
8. Zhao C., et al. In primary human monocyte-derived macrophages exposed to human immunodeficiency virus type 1, does the increased intracellular growth of Leishmania infantum rely on its enhanced uptake?. J. Gen. Virol. 87 (2006) 1295-1302
9. Wilflingseder D., et al. Mechanisms promoting dendritic cell-mediated transmission of HIV. Mol. Immunol. 42 (2005) 229-237
10. Colmenares M., et al. Dendritic cell (DC)-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN, CD209), a C-type surface lectin in human DCs, is a receptor for Leishmania amastigotes. J. Biol. Chem. 277 (2002) 36766-36769
11. Caparros E., et al. Role of the C-type lectins DC-SIGN and L-SIGN in Leishmania interaction with host phagocytes. Immunobiology 210 (2005) 185-193
12. Colmenares M., et al. The dendritic cell receptor DC-SIGN discriminates among species and life cycle forms of Leishmania. J. Immunol. 172 (2004) 1186-1190
13. Chakraborty D., et al. Leishmania donovani affects antigen presentation of macrophage by disrupting lipid rafts. J. Immunol. 175 (2005) 3214-3224
14. Appelmelk B.J., et al. Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J. Immunol. 170 (2003) 1635-1639
15. Cambi A., et al. Microdomains of the C-type lectin DC-SIGN are portals for virus entry into dendritic cells. J. Cell Biol. 164 (2004) 145-155
16. van Kooyk Y., and Geijtenbeek T.B. DC-SIGN: escape mechanism for pathogens. Nat. Rev. Immunol. 3 (2003) 697-709
17. Zhao C., et al. DC-SIGN-mediated transfer of HIV-1 is compromised by the ability of Leishmania infantum to exploit DC-SIGN as a ligand. J. Infect. Dis. 191 (2005) 1665-1669
18. Cameron P.U., et al. Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells. Science 257 (1992) 383-387
19. Cameron P.U., et al. During HIV-1 infection most blood dendritic cells are not productively infected and can induce allogeneic CD4+ T cells clonal expansion. Clin. Exp. Immunol. 88 (1992) 226-236
20. Das S.R., and Jameel S. Biology of the HIV Nef protein. Indian J. Med. Res. 121 (2005) 315-332
21. Sol-Foulon N., et al. HIV-1 Nef-induced upregulation of DC-SIGN in dendritic cells promotes lymphocyte clustering and viral spread. Immunity 16 (2002) 145-155
22. Chehimi J., et al. HIV-1 transmission and cytokine-induced expression of DC-SIGN in human monocyte-derived macrophages. J. Leukoc. Biol. 74 (2003) 757-763
23. Lekkerkerker A.N., et al. Viral piracy: HIV-1 targets dendritic cells for transmission. Curr. HIV Res. 4 (2006) 169-176
24. Woelbing F., et al. Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity. J. Exp. Med. 203 (2006) 177-188
25. Stoiber H., et al. Inhibition of HIV-1 infection in vitro by monoclonal antibodies to the complement receptor type 3 (CR3): an accessory role for CR3 during virus entry?. Mol. Immunol. 34 (1997) 855-863
26. Challacombe S.J., and Naglik J.R. The effects of HIV infection on oral mucosal immunity. Adv. Dent. Res. 19 (2006) 29-35
27. De Trez C., et al. Myd88-dependent in vivo maturation of splenic dendritic cells induced by Leishmania donovani and other Leishmania species. Infect. Immun. 72 (2004) 824-832
28. Becker I., et al. Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2. Mol. Biochem. Parasitol. 130 (2003) 65-74
29. Beignon A.S., et al. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J. Clin. Invest. 115 (2005) 3265-3275
30. Wille-Reece U., et al. HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates. Proc. Natl Acad. Sci. U. S. A. 102 (2005) 15190-15194
31. Heil F., et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303 (2004) 1526-1529
32. Lore K., et al. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses. J. Immunol. 171 (2003) 4320-4328
33. Alexander J., et al. An essential role for IL-13 in maintaining a non-healing response following Leishmania mexicana infection. Eur. J. Immunol. 32 (2002) 2923-2933
34. Satoskar A., et al. Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection. Infect. Immun. 63 (1995) 4894-4899
35. Stager S., et al. Both interleukin-4 (IL-4) and IL-4 receptor alpha signaling contribute to the development of hepatic granulomas with optimal antileishmanial activity. Infect. Immun. 71 (2003) 4804-4807
36. Lapenta C., et al. IFN-alpha-conditioned dendritic cells are highly efficient in inducing cross-priming CD8(+) T cells against exogenous viral antigens. Eur. J. Immunol. 36 (2006) 2046-2060
37. Becker Y. HIV-1 induced AIDS is an allergy and the allergen is the shed gp120 - a review, hypothesis, and implications. Virus Genes 28 (2004) 319-331
38. Banchereau J., et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18 (2000) 767-811
39. Koppelman B., et al. Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity 7 (1997) 861-871
40. Stanley A.C., and Engwerda C.R. Balancing immunity and pathology in visceral leishmaniasis. Immunol. Cell Biol. 85 (2007) 138-147
41. Ghosh M., et al. Leishmania donovani infection of human myeloid dendritic cells leads to a Th1 response in CD4+ T cells from healthy donors and patients with kala-azar. J. Infect. Dis. 194 (2006) 294-301
42. Ancuta P., et al. Opposite effects of IL-10 on the ability of dendritic cells and macrophages to replicate primary CXCR4-dependent HIV-1 strains. J. Immunol. 166 (2001) 4244-4253
43. Abdi K. IL-12: the role of p40 versus p75. Scand. J. Immunol. 56 (2002) 1-11
44. Ghosh M., and Bandyopadhyay S. Interaction of Leishmania parasites with dendritic cells and its functional consequences. Immunobiology 209 (2004) 173-177
45. McDowell M.A., et al. Leishmania priming of human dendritic cells for CD40 ligand-induced interleukin-12p70 secretion is strain and species dependent. Infect. Immun. 70 (2002) 3994-4001
46. Chougnet C., et al. Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus. J. Infect. Dis. 174 (1996) 46-53
47. Servet C., et al. Dendritic cells in innate immune responses against HIV. Curr. Mol. Med. 2 (2002) 739-756
48. Donaghy H., et al. Antigen presentation and the role of dendritic cells in HIV. Curr. Opin. Infect. Dis. 17 (2004) 1-6
49. Alfano M., and Poli G. Role of cytokines and chemokines in the regulation of innate immunity and HIV infection. Mol. Immunol. 42 (2005) 161-182
50. Soumelis V., et al. Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. Blood 98 (2001) 906-912
51. Schmidt B., et al. HIV-infected cells are major inducers of plasmacytoid dendritic cell interferon production, maturation, and migration. Virology 343 (2005) 256-266
52. Antoine J.C., et al. Leishmania spp.: on the interactions they establish with antigen-presenting cells of their mammalian hosts. Adv. Parasitol. 58 (2004) 1-68
53. Amprey J.L., et al. Inhibition of CD1 expression in human dendritic cells during intracellular infection with Leishmania donovani. Infect. Immun. 72 (2004) 589-592
54. Campos-Martin Y., et al. Immature human dendritic cells infected with Leishmania infantum are resistant to NK-mediated cytolysis but are efficiently recognized by NKT cells. J. Immunol. 176 (2006) 6172-6179
55. Moris A., et al. Dendritic cells and HIV-specific CD4+ T cells: HIV antigen presentation, T-cell activation, and viral transfer. Blood 108 (2006) 1643-1651
56. David A., et al. The engagement of activating FcgammaRs inhibits primate lentivirus replication in human macrophages. J. Immunol. 177 (2006) 6291-6300
57. Zhao C., et al. Leishmania infantum promotes replication of HIV type 1 in human lymphoid tissue cultured ex vivo by inducing secretion of the proinflammatory cytokines TNF-alpha and IL-1 alpha. J. Immunol. 172 (2004) 3086-3093
58. Naarding M.A., et al. Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes. J. Clin. Invest. 115 (2005) 3256-3264
59. Bajtay Z., et al. Expression and role of Fc- and complement-receptors on human dendritic cells. Immunol. Lett. 104 (2006) 46-52
60. Ito T., et al. Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J. Exp. Med. 204 (2007) 105-115
61. Brandonisio O., et al. Dendritic cells in Leishmania infection. Microbes Infect. 6 (2004) 1402-1409
62. Sundquist M., et al. Dendritic cells as inducers of antimicrobial immunity in vivo. APMIS 111 (2003) 715-724
63. Pron B., et al. Dendritic cells are early cellular targets of Listeria monocytogenes after intestinal delivery and are involved in bacterial spread in the host. Cell. Microbiol. 3 (2001) 331-340
64. Moll H., et al. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response. Eur. J. Immunol. 25 (1995) 693-699
65. Koppel E.A., et al. Distinct functions of DC-SIGN and its homologues L-SIGN (DC-SIGNR) and mSIGNR1 in pathogen recognition and immune regulation. Cell. Microbiol. 7 (2005) 157-165
66. Trinchieri G., and Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat. Rev. Immunol. 7 (2007) 179-190
67. Kelsall B.L., et al. Dendritic cells at the host-pathogen interface. Nat. Immunol. 3 (2002) 699-702
68. Shortman K., and Liu Y.J. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2 (2002) 151-161
69. Reis e Sousa C. Toll-like receptors and dendritic cells: for whom the bug tolls. Semin. Immunol. 16 (2004) 27-34
70. Geijtenbeek T.B., et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100 (2000) 587-597
71. Relloso M., et al. DC-SIGN (CD209) expression is IL-4 dependent and is negatively regulated by IFN, TGF-beta, and anti-inflammatory agents. J. Immunol. 168 (2002) 2634-2643
72. Grakoui A., et al. The immunological synapse: a molecular machine controlling T cell activation. Science 285 (1999) 221-227
73. Geijtenbeek T.B., et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100 (2000) 575-585
74. Brown G.D., and Gordon S. Immune recognition. A new receptor for beta-glucans. Nature 413 (2001) 36-37
75. Gantner B.N., et al. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J. Exp. Med. 197 (2003) 1107-1117